Protein Discovery

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Expedeon and Protein Discovery today announced that they have signed a merger agreement.

This story originally ran on Oct. 31 and has been updated to include comments from an industry executive and outside researcher.
By Adam Bonislawski

New Products

Premium

GE Healthcare, Protein Discovery

New Products

Premium

Agilent, Protein Discovery

New Products

Premium

Shimadzu, HealthLinx, Protein Discovery, GenScript

New Products

Premium

Protein Discovery

New Products

Premium

Eksigent, Protein Discovery, ChromoTek

The companies will market their protein analysis tools and develop new products.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.